Validated fluid biomarkers of AD include Aβ, total tau (t‐tau), various p‐tau isoforms, as well as multiple indicators of neuronal loss, axonal compromise, synaptic loss, and neurodegeneration.7 The gene discussed is MAPT; the disease is Alzheimer disease.